Peppermint

Lamiaceae

Mentha × piperita

Also known as: Peppermint Oil, Balm Mint, Black Peppermint

Pregnancy B2
Lactation B2

clinical_notes Clinical Summary

Peppermint (Mentha × piperita) is one of the most clinically well-supported herbal medicines for irritable bowel syndrome, with multiple systematic reviews and meta-analyses confirming superiority over placebo for global IBS symptoms and abdominal pain via its antispasmodic (calcium channel-blocking) and visceral pain-modulating mechanisms.

Its active constituent, menthol, also provides analgesic, antimicrobial, and cooling effects that underpin its use in headaches, colds, and topical muscle pain.

Clinicians should always use enteric-coated formulations for IBS to prevent upper GI release, and avoid use in GERD, bile duct obstruction, and in infants.

Pregnancy Safety

B2

Peppermint tea in food amounts is considered safe during pregnancy. Supplemental/medicinal doses of peppermint oil are not recommended during pregnancy due to insufficient safety data. Pulegone, found in small amounts, has demonstrated abortifacient effects at high doses in animal studies. EMA recommends limiting to 1–2 g/day leaf under medical supervision.

Lactation Safety

B2

Small amounts as tea (1-2 cups/day) are generally considered safe. High doses may reduce milk production (antilactogenic effect of menthol). Topical application near the breast should be wiped clean before nursing to avoid infant menthol exposure.

warning Contraindications

  • Gastroesophageal reflux disease (GERD) / Hiatal Hernia (avoid)
    Clinically Proven
  • Bile duct obstruction / severe gallbladder disease (contraindicated)
    Theoretical
  • Achlorhydria (absence of gastric acid) (avoid)
    Theoretical
  • Infants and children under 2 years (contraindicated)
    Clinically Proven

vital_signs Clinical Profile

Primary Indications

  • check_circle irritable bowel syndrome
  • check_circle abdominal cramping
  • check_circle bloating and flatulence
  • check_circle functional dyspepsia
  • check_circle nausea
  • check_circle tension headache
  • check_circle common cold
  • check_circle sinusitis
  • check_circle upper respiratory tract infection
  • check_circle muscle pain (topical)

Therapeutic Actions

antispasmodiccarminativeanalgesicantimicrobialanti-inflammatorycholagoguediaphoreticcoolingantinausea

System Affinities

  • check_circle digestive system
  • check_circle respiratory system
  • check_circle nervous system
  • check_circle musculoskeletal system

labs Active Constituents

menthol

menthone

menthyl acetate

1,8-cineole

pulegone

isomenthol

rosmarinic acid

luteolin

hesperidin

eriocitrin

history_edu Traditional Use

No TCM data available for this herb yet.

auto_stories

Traditional Uses Across Healing Systems

While many herbs lack controlled clinical trials, centuries of traditional practice across cultures provide valuable insight into their therapeutic applications.

Western Herbal Europe, North America
Documented since ancient Egypt and Greece; named by Linnaeus in 1753

Used extensively for digestive complaints including colic, bloating, nausea, and indigestion; applied topically for headache and muscle pain; used as a diaphoretic for fevers and colds.

Peppermint is a natural hybrid of watermint (M. aquatica) and spearmint (M. spicata). Commission E approved for IBS, dyspepsia, and catarrh of the upper respiratory tract.

Indigenous North America
Pre-colonial era

Various North American indigenous groups used native Mentha species for stomach complaints, fevers, and headaches.

Distinct from Mentha × piperita but overlapping in use with indigenous mints.

spa Parts Used

leaf

Constituents
mentholmenthonementhyl acetate1,8-cineolerosmarinic acidluteolinhesperidineriocitrin
Indications
  • IBS (as herbal tea)
  • indigestion
  • nausea
  • common cold
  • diaphoresis for fever
Preparation

Dried aerial parts used as infusion (tea) or in tincture. Commission E-approved for IBS and catarrh. Harvest before flowering for highest menthol content.

essential oil

Constituents
menthol (35-55%)menthone (15-30%)menthyl acetate (2-10%)1,8-cineole (3-8%)pulegone
Indications
  • IBS (enteric-coated capsules)
  • tension headache (topical)
  • muscle pain (topical)
  • nasal congestion (inhalation)
Preparation

Steam-distilled from aerial parts. Must be used in enteric-coated capsules for GI use to prevent upper-GI release. For topical use: dilute to 1-5% in carrier oil. Never apply pure essential oil to skin. Never use near face of infants.

shield Safety

Contraindications — Evidence Basis

Gastroesophageal reflux disease (GERD) / Hiatal Hernia
avoid Clinically Proven

Menthol relaxes the lower esophageal sphincter via calcium channel inhibition, significantly worsening reflux symptoms. Enteric-coated capsules reduce but do not eliminate this risk.

Bile duct obstruction / severe gallbladder disease
contraindicated Theoretical

Peppermint oil increases bile secretion and is contraindicated when bile flow is obstructed; risk of biliary colic. German Commission E monograph contraindicates use in biliary obstruction.

Achlorhydria (absence of gastric acid)
avoid Theoretical

Enteric coating of peppermint oil capsules requires acidic pH to remain intact. Achlorhydria prevents proper capsule integrity and may cause premature release in the upper GI tract.

Infants and children under 2 years
contraindicated Clinically Proven

Menthol applied to the face or nasal area of infants can cause laryngeal spasm and respiratory arrest. Do not use on or near the face of children under 2.

Toxicity

Toxic Dose

Large doses of pure menthol (>1 g/kg in adults) are toxic. Peppermint oil at >0.2 mL/kg considered potentially toxic.

Symptoms

Nausea, vomiting, CNS depression, ataxia, bradycardia, respiratory depression, seizures (at extremely high doses)

Management

Supportive care; activated charcoal if ingested within 1 hour; monitor respiratory status; seizures managed with benzodiazepines

Adverse Effects

heartburn and acid refluxperianal burningnauseaheadachecontact dermatitis (topical)bradycardia (high doses)muscle tremor (large doses)

CYP Metabolism

In vitro studies show menthol inhibits CYP3A4 and CYP2C9. Clinical significance at standard therapeutic doses appears minimal, but caution with narrow therapeutic index CYP3A4 substrates (e.g., ciclosporin, tacrolimus). Peppermint oil may also delay gastric emptying, affecting absorption of co-administered drugs.

swap_horiz Interactions

Iron Supplements

Decreased Effect low

Class: Mineral Supplement

Mechanism

Peppermint oil has been shown to inhibit iron absorption, likely through chelation effects or alteration of GI mucosa physiology. This reduces the bioavailability of concurrently administered iron supplements.

Clinical Guidance

Advise patients taking iron supplements to separate peppermint preparations by at least 2 hours to ensure adequate iron absorption. Monitor iron studies in patients using peppermint supplements alongside iron replacement therapy.

menu_book
Evidence Source Natural Medicines Database Peppermint monograph; Williamson EM et al. Stockley's Herbal Medicines Interactions 2013 Pharmaceutical Press View source open_in_new

Barbiturates and CNS Depressants

Increased Effect moderate

Class: CNS Depressant / Sedative

Mechanism

Acute and chronic peppermint oil pretreatment increased pentobarbitone-induced sleeping time and potentiated the analgesic effect of codeine in rodent models. Peppermint oil also enhanced motor impairment caused by midazolam. Mechanism likely involves CYP3A4 inhibition reducing metabolism of CNS depressant drugs.

Clinical Guidance

Caution patients using peppermint oil supplements against concurrent use with sedatives, opioid analgesics, or benzodiazepines. Monitor for excessive sedation. Advise against driving or operating machinery when combining peppermint oil with CNS depressants.

menu_book
Evidence Source Samojlik I et al. Phytother Res 2012;26(6):820-5. PMID: 22076909 View source open_in_new

Enteric-Coated Medications

Caution moderate

Class: Various (enteric-coated formulations)

Mechanism

Peppermint oil relaxes the lower esophageal sphincter and may prematurely dissolve enteric coatings by altering GI pH and motility, leading to drug release in the stomach rather than the intestine. This may cause GI irritation or reduce drug efficacy for medications requiring intestinal release.

Clinical Guidance

Avoid concurrent use of enteric-coated medications and peppermint oil capsules. Separate them by at least 1-2 hours. Patients taking enteric-coated aspirin or PPIs should be counselled about this interaction with peppermint oil supplements.

menu_book
Evidence Source Williamson EM, Driver S, Baxter K (Eds). Stockley Herbal Medicines Interactions 2013 Pharmaceutical Press; Natural Medicines Database View source open_in_new

Cyclosporine and Tacrolimus (CYP3A4 Substrates)

Increased Effect moderate

Class: Immunosuppressant

Mechanism

Single-dose peppermint oil (600 mg) inhibits intestinal CYP3A4, increasing AUC of CYP3A4 substrates such as felodipine in healthy volunteers. Animal studies confirm peppermint oil inhibits cyclosporine metabolism, increasing plasma levels. In vitro data also support inhibition of CYP2C9 and CYP2C19 by menthol and peppermint oil constituents.

Clinical Guidance

Monitor plasma levels of narrow therapeutic index CYP3A4 substrates (cyclosporine, tacrolimus) if high-dose peppermint oil is used concurrently. Consider separating oral doses from peppermint oil intake. Standard culinary peppermint use is unlikely to be clinically significant.

menu_book
Evidence Source Dresser GK, Wacher V, Wong S et al. Clin Pharmacol Ther 2002;72:247-55; Wacher VJ et al. J Pharm Sci 2002;91:77-90 View source open_in_new

Warfarin

Caution low

Class: Anticoagulant

Mechanism

In vitro studies demonstrate peppermint oil inhibits CYP2C9 and CYP2C19 at pharmacologically achievable concentrations. CYP2C9 is the primary enzyme responsible for S-warfarin metabolism; inhibition could theoretically increase warfarin plasma levels and anticoagulant effect. No human clinical case reports have confirmed this interaction.

Clinical Guidance

Monitor INR if patients on warfarin use high-dose peppermint oil supplements. Standard culinary use of peppermint tea is unlikely to be clinically significant. High-dose peppermint oil preparations warrant more caution.

menu_book
Evidence Source Unger M, Frank A. Rapid Commun Mass Spectrom 2004;18:2273-81; Dresser GK et al. Clin Pharmacol Ther 2002;72:247-55 View source open_in_new

Antacids

Antagonistic low

Class: Antacid

Mechanism

Peppermint oil relaxes the lower esophageal sphincter, potentially increasing gastroesophageal reflux and reducing effectiveness of antacids by promoting acid reflux into the esophagus. Enteric-coated peppermint oil products are designed to reduce this effect, but standard peppermint preparations may exacerbate reflux symptoms.

Clinical Guidance

Advise patients with GERD or acid reflux to use enteric-coated peppermint oil preparations rather than non-coated products. Separate peppermint oil dosing from antacids. Monitor reflux symptoms.

menu_book
Evidence Source WebMD Vitamins Peppermint monograph; Natural Medicines Database View source open_in_new

hub Combinations

info

Synergistic pairings can enhance therapeutic outcomes, while knowing suitable substitutes helps when specific herbs are unavailable or contraindicated.

auto_awesome

Synergistic Combinations

2
Ginger
Moderate Evidence
Rationale

Peppermint (antispasmodic) and ginger (antiemetic, prokinetic) provide complementary GI effects: peppermint reduces intestinal spasm while ginger accelerates gastric emptying and reduces nausea. Together they address multiple IBS and dyspepsia symptoms.

Clinical Evidence

Both herbs individually have meta-analytic evidence for GI indications; combination widely used in clinical practice for IBS with nausea component.

Lemon Balm
Strong Evidence
Rationale

The fixed combination of peppermint oil and lemon balm extract (Iberogast component) is widely used for functional dyspepsia and IBS. Lemon balm provides anxiolytic and antispasmodic effects that complement peppermint's direct smooth muscle relaxation.

Clinical Evidence

Iberogast (9-herb formula containing both) is EMA-approved for functional dyspepsia with significant RCT evidence.

handshake

Traditional Pairings

1
Echinacea
Traditional Use
Rationale

Echinacea (immune-stimulating) and peppermint (diaphoretic, decongestant, antimicrobial) are combined in traditional Western herbal formulas for colds and upper respiratory infections; peppermint relieves symptoms while echinacea addresses the immune response.

Clinical Evidence

Traditional combination; limited specific evidence for the pairing but both have individual evidence for URTI.

link Blumenthal M et al. Herbal Medicine: Expanded Commission E Monographs. Integrative Medicine Communications, 2000.

science Studies

search

Randomized Trial Examining Efficacy of Mentha piperita in Reducing Chronic Headache Discomfort in Youth

RCT
2023 |Pepper V, et al. Complement Ther Med. 2023;79:102990.

This randomised trial investigated whether brief peppermint aromatherapy reduces subjective and objective indicators of discomfort beyond passive relaxation in children and adolescents with chronic headaches. Youth with chronic headaches were allocated to either peppermint inhalation or a passive relaxation control. The peppermint group showed significantly greater reductions in headache-related discomfort scores compared with passive relaxation alone. These findings support peppermint aromatherapy as a low-risk, non-pharmacological adjunct for paediatric chronic headache management.

Tension Headache
analgesicantispasmodicTRPM8 receptor activation
View source open_in_new

Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome

Systematic Review
2022 |Ingrosso MR, Ianiro G, Nee J, et al. Aliment Pharmacol Ther. 2022;56(6):932-941.

This updated systematic review and meta-analysis searched the literature up to April 2022 to evaluate the efficacy and safety of peppermint oil in irritable bowel syndrome (IBS). RCTs were pooled using a random-effects model with efficacy assessed by dichotomous outcomes for global IBS symptoms or abdominal pain. Peppermint oil demonstrated statistically significant superiority over placebo for both global symptom relief and abdominal pain, with a favourable safety profile. The authors concluded that peppermint oil remains a clinically valid antispasmodic treatment for IBS, while also noting that recent trials have prompted reassessment of the magnitude of its benefit.

Irritable Bowel Syndrome (IBS)
antispasmodicsmooth muscle relaxationanti-inflammatory
View source open_in_new

medication Dosing

capsule

Dose Range

180–200 mg enteric-coated peppermint oil

Frequency

TID (3x daily)

Notes

Must use enteric-coated formulation for IBS to prevent premature release in the upper GI tract and heartburn. Take 30–60 minutes before meals. Do not co-administer with antacids.

tea

Dose Range

1–1.5 g dried peppermint leaf per 150 mL water

Frequency

2–3x daily

Notes

Steep 5–7 minutes covered, strain. Effective for nausea, mild indigestion, and colds. Avoid in symptomatic GERD. EMA-approved dosing for peppermint leaf tea.

topical

Dose Range

10% menthol solution or 2–4 drops essential oil diluted to 1–5% in carrier oil

Frequency

Apply to forehead/temples TID or as needed

Notes

For tension headache: apply diluted peppermint oil (10% ethanol solution) to forehead and temples. For muscle pain: 1–5% dilution in carrier oil. Never apply pure essential oil to skin. Avoid near eyes, mucous membranes. Never apply to face of children under 2.

smart_toy

Disclaimer: This information is largely AI-generated and reviewed by human experts at Evara Health. It is intended for educational and clinical reference purposes only and should not replace professional medical advice.

© 2026 Evara Health. All rights reserved.

Clinical Action Center

Export data for clinical use or patient education